In the rapidly evolving healthcare and wellness landscape, the intersection of genetics and nutrition has given rise to a groundbreaking field known as nutrigenomics. This field represents a paradigm shift in the understanding of how genes interact with the foods that people consume, paving the way for personalized nutrition tailored to individual genetic profiles. With its promise of precision and personalized health optimization, the market has captivated the attention of consumers, healthcare professionals, and industry stakeholders.
In addition, it has transitioned from a niche field of scientific research to a mainstream wellness consideration. As awareness grows and genetic testing becomes more accessible, consumers seek personalized nutritional guidance, driving the integration of Nutritional genomics into everyday health practices. The surge in popularity of direct-to-consumer genetic testing services has played a pivotal role in introducing individuals to nutrigenomics. Companies offering genetic testing kits, such as 23andMe and AncestryDNA, often include basic insights into traits related to nutrition, sparking curiosity and laying the foundation for more in-depth nutrigenomic analysis.
Urbanization in China has led to changes in lifestyle, including more sedentary behaviors and increased reliance on processed foods. It can help individuals adapt their diets to their genetic predispositions, considering factors such as metabolism and energy utilization to counteract the effects of sedentary lifestyles. As per the data provided in 2021 by the State Council of China, the overweight and obesity rate among adults is more than 50 percent, while that among children aged 6 to 17 years is 19 percent and children under 6 years is 10.4 percent. Thus, growing diabetes and obesity prevalence in Asia Pacific will boost the demand for Nutritional genomics in the region.
The China market dominated the Asia Pacific Nutrigenomics Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $101.3 Million by 2030. The Japan market is registering a CAGR of 16.7% during (2023 - 2030). Additionally, The India market would showcase a CAGR of 18.1% during (2023 - 2030).
Based on Product, the market is segmented into Reagents & Kits, and Services. Based on End User, the market is segmented into Hospitals & Clinics, Online Platforms, and Others. Based on Application, the market is segmented into Obesity, Diabetes, Cardiovascular Diseases, and Cancer Research. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
List of Key Companies Profiled
- Genova Diagnostics
- Metagenics, Inc.
- Nutrigenomix Inc.
- Unilever PLC
- The Gene Box
- Cura Integrative Medicine
- Fagron Genomics S.L.U. (GX Sciences Inc.)
- Xcode Life Sciences Private Limited
- DNA Life
- BASF SE
Market Report Segmentation
By Product- Reagents & Kits
- Services
- Hospitals & Clinics
- Online Platforms
- Others
- Obesity
- Diabetes
- Cardiovascular Diseases
- Cancer Research
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Table of Contents
Companies Mentioned
- Genova Diagnostics
- Metagenics, Inc.
- Nutrigenomix Inc.
- Unilever PLC
- The Gene Box
- Cura Integrative Medicine
- Fagron Genomics S.L.U. (GX Sciences Inc.)
- Xcode Life Sciences Private Limited
- DNA Life
- BASF SE
Methodology
LOADING...